174 related articles for article (PubMed ID: 30368237)
1. Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach.
Tahir Ul Qamar M; Bari A; Adeel MM; Maryam A; Ashfaq UA; Du X; Muneer I; Ahmad HI; Wang J
J Transl Med; 2018 Oct; 16(1):298. PubMed ID: 30368237
[TBL] [Abstract][Full Text] [Related]
2. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
Anwar S; Mourosi JT; Khan MF; Hosen MJ
Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
[TBL] [Abstract][Full Text] [Related]
4. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive immunoinformatics and target site study revealed the corner-stone toward Chikungunya virus treatment.
Hasan MA; Khan MA; Datta A; Mazumder MH; Hossain MU
Mol Immunol; 2015 May; 65(1):189-204. PubMed ID: 25682054
[TBL] [Abstract][Full Text] [Related]
6. In Silico Identification of Chikungunya Virus B- and T-Cell Epitopes with High Antigenic Potential for Vaccine Development.
Sánchez-Burgos GG; Montalvo-Marin NM; Díaz-Rosado ER; Pérez-Rueda E
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960629
[TBL] [Abstract][Full Text] [Related]
7. Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection.
Narula A; Pandey RK; Khatoon N; Mishra A; Prajapati VK
Infect Genet Evol; 2018 Jul; 61():4-15. PubMed ID: 29535024
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
9. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
Abdulla F; Adhikari UK; Uddin MK
Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
[TBL] [Abstract][Full Text] [Related]
10. In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya.
Jadoon MH; Rehman Z; Khan A; Rizwan M; Khan S; Mehmood A; Munir A
Infect Disord Drug Targets; 2020; 20(4):523-530. PubMed ID: 31109281
[TBL] [Abstract][Full Text] [Related]
11. Prediction of promiscuous epitopes in NSP2 of Chikungunya virus: An in-silico approach.
Fazal F; Anwar T; Waheed Y; Parvaiz F
Trop Biomed; 2020 Sep; 37(3):566-577. PubMed ID: 33612772
[TBL] [Abstract][Full Text] [Related]
12. An
Venkatesan A; Chouhan U; Suryawanshi SK; Choudhari JK
Immunol Med; 2023 Dec; 46(4):163-174. PubMed ID: 37078425
[TBL] [Abstract][Full Text] [Related]
13. Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach.
Ahmad B; Ashfaq UA; Rahman MU; Masoud MS; Yousaf MZ
Microb Pathog; 2019 Jul; 132():243-253. PubMed ID: 31075428
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Epitope Prediction of Chikungunya Virus.
Eng CL; Tan TW; Tong JC
Methods Mol Biol; 2016; 1426():201-7. PubMed ID: 27233273
[TBL] [Abstract][Full Text] [Related]
15. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.
Adhikari UK; Tayebi M; Rahman MM
J Immunol Res; 2018; 2018():6718083. PubMed ID: 30402510
[TBL] [Abstract][Full Text] [Related]
16. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
[TBL] [Abstract][Full Text] [Related]
17. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus.
Sharma S; Kumari V; Kumbhar BV; Mukherjee A; Pandey R; Kondabagil K
Immunobiology; 2021 Mar; 226(2):152053. PubMed ID: 33517154
[TBL] [Abstract][Full Text] [Related]
19. Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of
Elamin Elhasan LM; Hassan MB; Elhassan RM; Abdelrhman FA; Salih EA; Ibrahim H A; Mohamed AA; Osman HS; Khalil MSM; Alsafi AA; Idris AB; Hassan MA
J Immunol Res; 2021; 2021():8280925. PubMed ID: 34036109
[TBL] [Abstract][Full Text] [Related]
20. In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses.
Mahmoodi S; Amirzakaria JZ; Ghasemian A
PLoS One; 2023; 18(5):e0285177. PubMed ID: 37146081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
